Arellano, Lea F.

HRN: 01-44-73  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/16/2023
CEFUROXIME 1.5GM (VIAL)
02/16/2023
02/23/2023
IVTT
1.5g
Q8h
Fracture, Closed, Complete, Displaced, Radius-Ulna, Left Sec To MVA
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: